UKCRC Registered Clinical Trials Unit

The MRC Clinical Trials Unit (MRC CTU) at UCL is a centre of excellence for clinical trials, meta-analyses and epidemiological studies.

We are committed to strengthening and expanding the evidence base for healthcare nationally and internationally.

The MRC CTU at UCL also develops methodology to improve the design, conduct and analysis of clinical studies, and hosts one of the MRC’s eight regional Hubs for Trials Methodology Research.

The MRC CTU at UCL is a UKCRC registered trials unit.


Read more about the Unit

Series of short films about clinical trials

Clinical trials are essential to finding out whether new healthcare interventions (such as new drugs) work. We have produced a series of short films, exploring:

  • What are randomised controlled trials and why are they important?
  • What is the MRC Clinical Trials Unit, and what does it do?
  • Where do ideas for trials come from?

and much more...

REMoxTB trial finds substituting Moxifloxacin in standard tuberculosis treatment does not shorten treatment to four months
The REMoxTB trial has found that replacing one of the drugs in the standard six-month treatment regimen with the antibiotic moxifloxacin did not allow the treatment time for tuberculosis (TB) patients to be shortened to four months. The results were presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and published in the New England Journal of Medicine on 7 September.

Read more